Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-20 Purchase |
2023-01-24 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
1,923,076 | $13 | $24,999,988 | 11,609,704 (Indirect) |
View |
| 2023-01-13 Sale |
2023-01-13 6:33 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO |
6,766 | $15 | $101,490 | 499,864 (Direct) |
View |
| 2023-01-04 Purchase |
2023-01-06 4:39 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
180,703 | $7.2761 | $1,314,806 | 9,686,628 (Indirect) |
View |
| 2022-12-27 Purchase |
2022-12-29 5:00 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
4,089 | $5.9941 | $24,510 | 9,505,925 (Indirect) |
View |
| 2022-12-19 Purchase |
2022-12-21 4:30 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
98,787 | $5.8997 | $582,814 | 9,501,836 (Indirect) |
View |
| 2022-12-14 Purchase |
2022-12-16 4:41 pm |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
2,403,049 | $5.4405 | $13,073,874 | 9,403,049 (Indirect) |
View |
| 2022-06-07 Sale |
2022-06-08 7:33 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $8.0898 | $577,895 | 593,153 (Direct) |
View |
| 2022-06-02 Sale |
2022-06-06 7:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $7.9975 | $532,810 | 1,054,819 (Direct) |
View |
| 2022-04-07 Sale |
2022-04-11 5:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $24.02 | $135,228 | 731,210 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 7:00 pm |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $24.16 | $2,276,684 | 1,309,602 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-09 Option Award |
2023-02-13 4:15 pm |
N/A 2033-02-08 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 4:15 pm |
N/A 2033-02-08 |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller |
16,100 | $0 | 16,100 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 4:15 pm |
N/A 2033-02-08 |
Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 4:15 pm |
N/A 2033-02-08 |
Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-12-13 Other |
2022-12-15 4:30 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC TEPPER ROBERT I 10% Owner |
2,000,000 | $0 | 6,461,545 (Direct) |
View |
| 2022-11-07 Option Award |
2022-11-09 4:15 pm |
N/A 2032-11-06 |
Fulcrum Therapeutics Inc. | FULC | Arroyo Santiago Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2022-11-09 4:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Arroyo Santiago Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-08-26 4:39 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 7,000,000 (Indirect) |
View |
| 2022-08-09 Option Award |
2022-08-11 4:15 pm |
N/A 2032-08-08 |
Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer |
137,000 | $0 | 137,000 (Direct) |
View |
| 2022-08-09 Option Award |
2022-08-11 4:15 pm |
N/A 2032-08-08 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2022-08-11 4:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer |
0 | $0 | 190,000 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:15 pm |
N/A 2032-07-14 |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller |
16,540 | $0 | 16,540 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
19,000 | $0 | 33,500 (Direct) |
View |
| 2022-06-28 Other |
2022-06-29 5:00 pm |
N/A 2030-12-02 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
500 | $0 | 33,500 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:00 pm |
N/A 2032-06-26 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2022-06-07 Exercise |
2022-06-08 7:33 pm |
N/A 2022-06-30 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $0 | 593,153 (Direct) |
View |
| 2022-06-07 Exercise |
2022-06-08 7:33 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
71,435 | $7.84 | 593,153 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 7:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $0 | 1,054,819 (Direct) |
View |
| 2022-06-02 Exercise |
2022-06-06 7:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
66,622 | $7.84 | 1,054,819 (Direct) |
View |
| 2022-05-06 Option Award |
2022-05-10 4:15 pm |
N/A 2032-05-05 |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller |
9,750 | $0 | 22,702 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 5:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $0 | 731,210 (Direct) |
View |
| 2022-04-07 Exercise |
2022-04-11 5:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
5,631 | $7.84 | 731,210 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:00 pm |
N/A 2029-01-21 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $0 | 1,309,602 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:00 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
94,251 | $7.84 | 1,309,602 (Direct) |
View |
Ownership |
2022-03-14 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Controller |
0 | $0 | 35,906 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Thomson Peter G. VP Finance & Accounting |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Dunn Judith See Remarks |
140,890 | $0 | 140,890 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Stuart Bryan See Remarks |
340,000 | $0 | 340,000 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Morabito Christopher Chief Medical Officer |
59,744 | $0 | 59,744 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 4:15 pm |
N/A 2032-01-18 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-10 4:30 pm |
N/A 2032-01-02 |
Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2022-01-10 4:16 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Rajavelu Esther Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-12-17 Ownership |
2022-01-07 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale SVP, General Counsel |
1,088 | $0 | 1,248 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-09 4:30 pm |
N/A 2031-12-07 |
Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director |
30,000 | $0 | 30,000 (Direct) |
View |